FG
AZN icon

Foresight Group’s AstraZeneca AZN Stock Holding History

Foresight Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-85,543
Closed -$13.1M – 61
2025
Q3 		$13.1M Sell
85,543
-12,403
-13% -$1.88M 1.96% 23
2025
Q2 		$27.2M Sell
97,946
-10,966
-10% -$1.54M 3.85% 8
2025
Q1 		$31.6M Buy
+108,912
New +$15.8M 4.46% 5

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Foresight Group's AZN Position: Q4 2025 in Review

Foresight Group sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 85,543 shares — an estimated $13.1M sold.

Foresight Group first reported a position in AZN in Q1 2025 and held it in 3 quarters. The position peaked at $31.6M in Q1 2025. 1,406 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

  • Foresight Group reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
  • Foresight Group sold 85,543 AstraZeneca shares in Q4 2025, an estimated $13.1M.
  • Foresight Group first reported a position in AstraZeneca in Q1 2025 and held it in 3 quarters.
  • Foresight Group's AstraZeneca position peaked at $31.6M in Q1 2025.
  • 1,406 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on Foresight Group's 13F filing for Q4 2025, filed 17 Feb 2026.